Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
Accent Therapeutics Presents Data Reinforcing Therapeutic Potential of Novel KIF18A Inhibitor, ATX-295, at the 2026 American Association for Cancer Research Annual Meeting
17 Apr 2026
PR Newswire Association LLC.
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17 Apr 2026
GlobeNewswire
Zentalis Pharmaceuticals To Present Azenosertib Preclinical Data in Triple-Negative Breast Cancer and Real-World Analysis of Unmet Need in Cyclin E1-Positive Ovarian Cancer at AACR 2026
17 Apr 2026
GlobeNewswire
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17 Apr 2026
GlobeNewswire
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17 Apr 2026
PR Newswire Association LLC.
Immunitas Presents Phase 1/2a Data Highlighting Anti-Tumor Activity of Novel Immunotherapy IMT-009 at AACR 2026 Annual Meeting
17 Apr 2026
PR Newswire Association LLC.
Kalohexis Announces Poster Presentation at the American Association for Cancer Research Annual Meeting 2026
17 Apr 2026
PR Newswire Association LLC.
Simpli5 Team Intelligence Platform Linked to Measurable Gains in Clinical Quality Across Healthcare Organizations
17 Apr 2026
GlobeNewswire
Revolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
17 Apr 2026
GlobeNewswire
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
17 Apr 2026
GlobeNewswire
Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting
17 Apr 2026
PR Newswire Association LLC.
Laurent C.A. Melchior Tellier Returns to Original Role as CEO of Genomic Prediction
17 Apr 2026
PR Newswire Association LLC.
New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test
17 Apr 2026
GlobeNewswire
Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026
17 Apr 2026
PR Newswire Association LLC.
New Clinical and Preclinical Data for Investigational Candidate Zidesamtinib Presented at AACR Annual Meeting 2026
17 Apr 2026
PR Newswire Association LLC.
Annals of Internal Medicine presents breaking scientific news at ACP's Internal Medicine Meeting 2026
17 Apr 2026
GlobeNewswire
ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Research (AACR) Annual Meeting
17 Apr 2026
PR Newswire Association LLC.
New ACP Breast Cancer Screening Guidelines Are a Step Backward that May Cost Lives
17 Apr 2026
PR Newswire Association LLC.
Nested Therapeutics Reports Initial Encouraging Clinical Activity and Favorable Tolerability of NST-628, a Brain-Penetrant Pan-RAF/MEK Molecular Glue, at AACR 2026
17 Apr 2026
PR Newswire Association LLC.
The Melanoma Research Foundation Launches its Inaugural Washington DC 5K Fundraiser with a Goal of $115,000 in Support of Melanoma Research, Education and Advocacy
17 Apr 2026
GlobeNewswire
Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
17 Apr 2026
GlobeNewswire
Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting
17 Apr 2026
PR Newswire Association LLC.
New guidance from ACP says all average-risk females aged 50-74 should undergo biennial mammography screening for breast cancer
17 Apr 2026
PR Newswire Association LLC.
Lunit to Present Six AI Studies at AACR 2026 Highlighting Advances in Precision Oncology and Real-World Clinical Application
17 Apr 2026
GlobeNewswire
Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2
17 Apr 2026
GlobeNewswire
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
17 Apr 2026
PR Newswire Association LLC.
Glaucoma Foundation Celebrates 42nd Anniversary - Honoree Pledges $5 Million Dollars for Glaucoma Research
17 Apr 2026
Upcoming Events All Events
- April 2026
- Seattle: Life Science Innovation Northwest 2026
- Leipzig: German Biotech Days
- Shanghai: ChinaBio® Partnering Forum